{"count": 18, "results": [{"_id": "37648584", "pmid": 37648584, "title": "Renin-angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry.", "journal": "Eur J Intern Med", "authors": ["Menichelli D", "Poli D", "Antonucci E", "Palareti G", "Pignatelli P", "Pastori D", "START2 Register Investigators"], "date": "2023-08-28T00:00:00Z", "doi": "10.1016/j.ejim.2023.08.019", "meta_date_publication": "2023 Aug 28", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50240.24, "text_hl": "BACKGROUND: Arterial @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ is the most common @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular@@@ comorbidity in @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ (@<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@). ", "citations": {"NLM": "Menichelli D, Poli D, Antonucci E, Palareti G, Pignatelli P, Pastori D, START2 Register Investigators. Renin-angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry. Eur J Intern Med. 2023 Aug 28;():. PMID: 37648584", "BibTeX": "@article{37648584, title={Renin-angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry.}, author={Menichelli D and Poli D and Antonucci E and Palareti G and Pignatelli P and Pastori D and START2 Register Investigators}, journal={Eur J Intern Med}}"}}, {"_id": "33965157", "pmid": 33965157, "title": "An 84-Year-Old Physician With Progressive Dyspnea and Bilateral Upper Lobe Opacities.", "journal": "Chest", "authors": ["Harris ZM", "Antin-Ozerkis D"], "date": "2021-05-01T00:00:00Z", "doi": "10.1016/j.chest.2020.12.035", "meta_date_publication": "2021 May", "meta_volume": "159", "meta_issue": "5", "meta_pages": "e325-e329", "score": 50237.082, "text_hl": "Medical history included paroxysmal @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@, @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, @DISEASE_Hashimoto_Disease @DISEASE_MESH:D050031 @@@Hashimoto's thyroiditis@@@, and @DISEASE_Carnevale_syndrome @DISEASE_MESH:C535586 @@@OSA@@@. ", "citations": {"NLM": "Harris ZM, Antin-Ozerkis D. An 84-Year-Old Physician With Progressive Dyspnea and Bilateral Upper Lobe Opacities. Chest. 2021 May;159(5):e325-e329. PMID: 33965157", "BibTeX": "@article{33965157, title={An 84-Year-Old Physician With Progressive Dyspnea and Bilateral Upper Lobe Opacities.}, author={Harris ZM and Antin-Ozerkis D}, journal={Chest}, volume={159}, number={5}, pages={e325-e329}}"}}, {"_id": "28886992", "pmid": 28886992, "title": "Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).", "journal": "J Cardiol", "authors": ["Yamabe H", "Kaikita K", "Matsumura T", "Iwasa A", "Koyama J", "Uemura T", "Morikami Y", "Tsunoda R", "Morihisa K", "Fujimoto K", "Kajiwara I", "Matsui K", "Tsujita K", "Ogawa H"], "date": "2018-02-01T00:00:00Z", "doi": "10.1016/j.jjcc.2017.07.010", "meta_date_publication": "2018 Feb", "meta_volume": "71", "meta_issue": "2", "meta_pages": "129-134", "score": 50067.094, "text_hl": "There was no significant difference in the @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@/@DISEASE_Tachycardia_Supraventricular @DISEASE_MESH:D013617 @@@AT@@@ recurrence between the @CHEMICAL_Irbesartan @CHEMICAL_MESH:D000077405 @@@irbesartan@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ groups. ", "citations": {"NLM": "Yamabe H, Kaikita K, Matsumura T, Iwasa A, Koyama J, Uemura T, Morikami Y, Tsunoda R, Morihisa K, Fujimoto K, Kajiwara I, Matsui K, Tsujita K, Ogawa H. Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study). J Cardiol. 2018 Feb;71(2):129-134. PMID: 28886992", "BibTeX": "@article{28886992, title={Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).}, author={Yamabe H and Kaikita K and Matsumura T and Iwasa A and Koyama J and Uemura T and Morikami Y and Tsunoda R and Morihisa K and Fujimoto K and Kajiwara I and Matsui K and Tsujita K and Ogawa H}, journal={J Cardiol}, volume={71}, number={2}, pages={129-134}}"}}, {"_id": "18356684", "pmid": 18356684, "title": "Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.", "journal": "J Cardiovasc Pharmacol", "authors": ["Fogari R", "Zoppi A", "Mugellini A", "Corradi L", "Lazzari P", "Preti P", "Derosa G"], "date": "2008-03-01T00:00:00Z", "doi": "10.1097/FJC.0b013e318160b42a", "meta_date_publication": "2008 Mar", "meta_volume": "51", "meta_issue": "3", "meta_pages": "217-22", "score": 50065.72, "text_hl": "The aim of this study was to compare the effect of @CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ combination in preventing the recurrence of @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ (@<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@) in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive diabetic@@@ @SPECIES_9606 @@@patients@@@ with a history of recent paroxysmal @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@. ", "citations": {"NLM": "Fogari R, Zoppi A, Mugellini A, Corradi L, Lazzari P, Preti P, Derosa G. Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus. J Cardiovasc Pharmacol. 2008 Mar;51(3):217-22. PMID: 18356684", "BibTeX": "@article{18356684, title={Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.}, author={Fogari R and Zoppi A and Mugellini A and Corradi L and Lazzari P and Preti P and Derosa G}, journal={J Cardiovasc Pharmacol}, volume={51}, number={3}, pages={217-22}}"}}, {"_id": "18300848", "pmid": 18300848, "title": "Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.", "journal": "J Hypertens", "authors": ["Schmieder RE", "Kjeldsen SE", "Julius S", "McInnes GT", "Zanchetti A", "Hua TA", "VALUE Trial Group"], "date": "2008-03-01T00:00:00Z", "doi": "10.1097/HJH.0b013e3282f35c67", "meta_date_publication": "2008 Mar", "meta_volume": "26", "meta_issue": "3", "meta_pages": "403-11", "score": 50063.062, "text_hl": "The incidence of persistent @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@ was 1.35% with @CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@ and 1.97% with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ [unadjusted hazard ratio 0.683 (95% CI: 0.525, 0.889), P = 0.0046]. ", "citations": {"NLM": "Schmieder RE, Kjeldsen SE, Julius S, McInnes GT, Zanchetti A, Hua TA, VALUE Trial Group. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial. J Hypertens. 2008 Mar;26(3):403-11. PMID: 18300848", "BibTeX": "@article{18300848, title={Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.}, author={Schmieder RE and Kjeldsen SE and Julius S and McInnes GT and Zanchetti A and Hua TA and VALUE Trial Group}, journal={J Hypertens}, volume={26}, number={3}, pages={403-11}}"}}, {"_id": "16424784", "pmid": 16424784, "title": "Losartan and prevention of atrial fibrillation recurrence in hypertensive patients.", "journal": "J Cardiovasc Pharmacol", "authors": ["Fogari R", "Mugellini A", "Destro M", "Corradi L", "Zoppi A", "Fogari E", "Rinaldi A"], "date": "2006-01-01T00:00:00Z", "doi": "10.1097/01.fjc.0000193808.99773.28", "meta_date_publication": "2006 Jan", "meta_volume": "47", "meta_issue": "1", "meta_pages": "46-50", "score": 50062.96, "text_hl": "The aim of the study was to evaluate the effect of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ as compared with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, both associated with @CHEMICAL_Amiodarone @CHEMICAL_MESH:D000638 @@@amiodarone@@@, in preventing the recurrence of @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ (@<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@) in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with a history of recent paroxysmal @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@. ", "citations": {"NLM": "Fogari R, Mugellini A, Destro M, Corradi L, Zoppi A, Fogari E, Rinaldi A. Losartan and prevention of atrial fibrillation recurrence in hypertensive patients. J Cardiovasc Pharmacol. 2006 Jan;47(1):46-50. PMID: 16424784", "BibTeX": "@article{16424784, title={Losartan and prevention of atrial fibrillation recurrence in hypertensive patients.}, author={Fogari R and Mugellini A and Destro M and Corradi L and Zoppi A and Fogari E and Rinaldi A}, journal={J Cardiovasc Pharmacol}, volume={47}, number={1}, pages={46-50}}"}}, {"_id": "18566593", "pmid": 18566593, "title": "Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation.", "journal": "Am J Hypertens", "authors": ["Fogari R", "Derosa G", "Ferrari I", "Corradi L", "Zoppi A", "Lazzari P", "Santoro T", "Preti P", "Mugellini A"], "date": "2008-09-01T00:00:00Z", "doi": "10.1038/ajh.2008.217", "meta_date_publication": "2008 Sep", "meta_volume": "21", "meta_issue": "9", "meta_pages": "1034-9", "score": 50062.8, "text_hl": "A total of 46 (47.4%) @SPECIES_9606 @@@patients@@@ treated with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ had a recurrence of @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@ as did 26 (27.9%) @SPECIES_9606 @@@patients@@@ treated with @CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@ramipril@@@ (P < 0.01 vs. ", "citations": {"NLM": "Fogari R, Derosa G, Ferrari I, Corradi L, Zoppi A, Lazzari P, Santoro T, Preti P, Mugellini A. Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation. Am J Hypertens. 2008 Sep;21(9):1034-9. PMID: 18566593", "BibTeX": "@article{18566593, title={Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation.}, author={Fogari R and Derosa G and Ferrari I and Corradi L and Zoppi A and Lazzari P and Santoro T and Preti P and Mugellini A}, journal={Am J Hypertens}, volume={21}, number={9}, pages={1034-9}}"}}, {"_id": "21335482", "pmid": 21335482, "title": "Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation.", "journal": "J Cardiovasc Pharmacol Ther", "authors": ["Fogari R", "Mugellini A", "Zoppi A", "Preti P", "Destro M", "Lazzari P", "Derosa G"], "date": "2012-03-01T00:00:00Z", "doi": "10.1177/1074248410395018", "meta_date_publication": "2012 Mar", "meta_volume": "17", "meta_issue": "1", "meta_pages": "34-43", "score": 50062.07, "text_hl": "Ventricular rate and TnI at the first @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@ recurrence were significantly lower with @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@ and @CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@ramipril@@@ than with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@. ", "citations": {"NLM": "Fogari R, Mugellini A, Zoppi A, Preti P, Destro M, Lazzari P, Derosa G. Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation. J Cardiovasc Pharmacol Ther. 2012 Mar;17(1):34-43. PMID: 21335482", "BibTeX": "@article{21335482, title={Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation.}, author={Fogari R and Mugellini A and Zoppi A and Preti P and Destro M and Lazzari P and Derosa G}, journal={J Cardiovasc Pharmacol Ther}, volume={17}, number={1}, pages={34-43}}"}}, {"_id": "22522403", "pmid": 22522403, "title": "Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size.", "journal": "Clin Cardiol", "authors": ["Fogari R", "Zoppi A", "Maffioli P", "Mugellini A", "Preti P", "Perrone T", "Derosa G"], "date": "2012-06-01T00:00:00Z", "doi": "10.1002/clc.21994", "meta_date_publication": "2012 Jun", "meta_volume": "35", "meta_issue": "6", "meta_pages": "359-64", "score": 50060.156, "text_hl": "CONCLUSIONS: @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@Telmisartan@@@ was more effective than @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ in preventing @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@AF@@@ recurrences in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@paroxysmal AF@@@.", "citations": {"NLM": "Fogari R, Zoppi A, Maffioli P, Mugellini A, Preti P, Perrone T, Derosa G. Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size. Clin Cardiol. 2012 Jun;35(6):359-64. PMID: 22522403", "BibTeX": "@article{22522403, title={Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size.}, author={Fogari R and Zoppi A and Maffioli P and Mugellini A and Preti P and Perrone T and Derosa G}, journal={Clin Cardiol}, volume={35}, number={6}, pages={359-64}}"}}, {"_id": "12891296", "pmid": 12891296, "title": "[Effect of calcium antagonists verapamil and amlodipine on the risk of development of atrial fibrillation after coronary artery bypass grafting].", "journal": "Kardiologiia", "authors": ["Popov SV", "Kandinskiĭ ML", "Kozlov BN", "Antonchenko IV", "Evtushenko AV", "Dzhavadova GK", "Vecherskiĭ IuIu", "Akhmedov ShD", "Afanas'ev SA", "Shipulin VM"], "date": "2003-01-01T00:00:00Z", "meta_date_publication": "2003", "meta_volume": "43", "meta_issue": "7", "meta_pages": "27-30", "score": 50059.773, "text_hl": "[Effect of calcium antagonists @CHEMICAL_Verapamil @CHEMICAL_MESH:D014700 @@@verapamil@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on the risk of development of @<m>DISEASE_Atrial_Fibrillation</m> @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ after coronary artery bypass grafting].", "citations": {"NLM": "Popov SV, Kandinskiĭ ML, Kozlov BN, Antonchenko IV, Evtushenko AV, Dzhavadova GK, Vecherskiĭ IuIu, Akhmedov ShD, Afanas'ev SA, Shipulin VM. [Effect of calcium antagonists verapamil and amlodipine on the risk of development of atrial fibrillation after coronary artery bypass grafting]. Kardiologiia. 2003;43(7):27-30. PMID: 12891296", "BibTeX": "@article{12891296, title={[Effect of calcium antagonists verapamil and amlodipine on the risk of development of atrial fibrillation after coronary artery bypass grafting].}, author={Popov SV and Kandinskiĭ ML and Kozlov BN and Antonchenko IV and Evtushenko AV and Dzhavadova GK and Vecherskiĭ IuIu and Akhmedov ShD and Afanas'ev SA and Shipulin VM}, journal={Kardiologiia}, volume={43}, number={7}, pages={27-30}}"}}]}